The EUROSCA Natural History Study
NCT02440763
Recruiting
The key goals of EUROSCA-NHS is to determine and compare the rate of disease progression in SCA1, SCA2, SCA3 and SCA6 including determination of the order and occurrence of non-ataxia symptoms, assessment of activities of daily living (ADL) and quality of life (QoL), and identification of predictors of disease progression and survival.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/28/2017
Locations: Department of Neurology, Medical University, Innsbruck, Innsbruck, Not set +15 locations
Conditions: Spinocerebellar Ataxia
Register for Updates